A Comparative Study Of PF-06439535 Plus Paclitaxel-Carboplatin And Bevacizumab Plus Paclitaxel-Carboplatin Patients With Advanced Non-Squamous NSCLC

A Phase 3 Randomized, Double-Blind Study of PF-06439535 Plus Paclitaxel-Carboplatin and Bevacizumab Plus Paclitaxel Carboplatin for the First-Line Treatment of Patients With Advanced Non-Squamous Non-Small Cell Lung Cancer

Category & Conditions:
Cancer
Medicine:
ZIRABEV INJECTION(BEVACIZUMAB-BVZR)
ClinicalTrials.gov Identifier (NCT):
Protocol ID:
B7391003
Open Plain Language Summary Result:Click here